2019 annual financial data

Xenon Pharmaceuticals 2019 Operating margin

Xenon Pharmaceuticals 2019 operating margin with verified reported values.

Direct answer

Operating margin was -627.02%.

Operating income was -42,819,000 USD and net income was -41,595,000 USD.
Operating cash flow was -4,632,000 USD.

Get free Xenon Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6,829,000 USD
Operating income
-42,819,000 USD
Net income
-41,595,000 USD
Operating cash flow
-4,632,000 USD